Familial paraganglioma due to a novel SDHB mutation: familial phenotypic heterogeneity and a potentially novel manifestation
Author(s) -
Ali S. Alzahrani,
Meshael Alswailem,
Shatha Albattal,
Ebtesam Qasem,
Avaniyapuram Kannan Murugan,
Hindi AlHindi
Publication year - 2019
Publication title -
international journal of endocrine oncology
Language(s) - English
Resource type - Journals
eISSN - 2045-0877
pISSN - 2045-0869
DOI - 10.2217/ije-2018-0003
Subject(s) - penetrance , paraganglioma , sdhb , medicine , primary hyperparathyroidism , genetic heterogeneity , phenotype , family history , parathyroidectomy , pheochromocytoma , mutation , parathyroid adenoma , parathyroid hormone , pathology , endocrinology , germline mutation , genetics , biology , gene , calcium
Non-paraganglioma (PGL) tumors are rare manifestations of familial PGL syndromes. Primary hyperparathyroidism has not been described in PGL syndromes. We present a 36-year-old man with a history of right carotid body tumor at 24 years and an abdominal PGL at 31 years of age. At 35 years, he developed hypercalcemia (serum Ca 2.65–2.72 mmol/l), and high parathyroid hormone of 92–131 ng/l (normal range, 15–65) and a Tc99 Sestamibi scan showed a single parathyroid adenoma which was confirmed on histopathological examination of parathyroidectomy. Recently, he was diagnosed with a left glomus jugulare which has not been operated on yet. His family history is strongly positive for PGLs. Genetic testing revealed a novel SDHB mutation (p.K137E) but the phenotype and penetrance were variable in different family members.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom